Senate Democrats intend to grill the executives of three major pharmaceutical companies at a hearing at the start of next year’s legislative session, setting an aggressive prescription drug price agenda for 2024.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.